- Pfizer, Moderna and Alnylam flag pharma labor shortage in Massachusetts—and the people bottleneck doesn’t stop there (fiercepharma.com)
Raw materials and limits on high-tech equipment often take center stage when it comes to discussions around manufacturing bottlenecks. But the COVID-19 pandemic has exposed another weak link in the pharmaceutical supply chain: people...As COVID-19 vaccine production moves full-tilt, mRNA players Pfizer and Moderna are having trouble recruiting talent...Hiring challenges, which have been exacerbated by the pandemic, aren’t unique to COVID-19 vaccine makers...READ MORE
- Dubbed ‘Baby Doc,’ medical school graduate serves in Nevada Air Guard (reviewjournal.com)
Nevada Air Guard Capt. Caleena Longworth knew at the age of 10 that she wanted to be a doctor, and by January of this year, in the final semester of her medical doctorate program, she was one class away...With the class not set to begin until April, UNLV’s Kirk Kerkorian School of Medicine offered her a two-month vacation. Instead, Longworth, an Air Force veteran and native of Reno, started administering thousands of vaccinations to Nevadans at Cashman Center...READ MORE
- S.Africa’s Ramaphosa accuses Big Pharma of ‘selfish, unjust’ vaccine policy (reuters.com)
South Africa's president said...the "selfish, unjust" refusal of pharmaceutical companies and allied Western governments to entertain emergency patent waivers on COVID-19 vaccines was endangering the entire world...In unusually impassioned remarks, Cyril Ramaphosa lambasted a resistance to calls by India and South Africa for temporary patent waivers to ramp up production...The proposed waiver from the WTO's agreement on Trade-Related Aspects of Intellectual Property Rights has support in principle from U.S. President Joe Biden and French President Emmanuel Macron...But the pharmaceutical industry is against the waiver, as are Germany, Switzerland and the World Bank. They argue it would stifle innovation and that vaccine supplies are constrained by a lack of manufacturing capacity...READ MORE
- EU Hits AstraZeneca Vaccine with Another Blood Condition for Side Effect List (biospace.com)
The AstraZeneca COVID-19 vaccine takes another hit to its safety profile as the European Medicines Agency adds a new side effect to the label of its shot...The EMA identified a rare blood condition, capillary leak syndrome, as a potential side effect of AstraZeneca’s Vaxzevria. The condition causes plasma leaks from blood vessels into neighboring body cavities and muscles. Blood pressure experiences a sharp drop as a result, and, left untreated, the disorder can lead to organ failure and death...READ MORE
- U.S. Drug-Overdose Deaths Soared Nearly 30% in 2020, Driven by Synthetic Opioids (wsj.com)Provisional Drug Overdose Death Counts (cdc.gov)Chinese and Mexican Cartels Exploit the Border Crisis to Smuggle More Fentanyl Into the U.S. (immigrationreform.com)Fentanyl Flow to the United States (dea.gov)
Drug-overdose deaths in the U.S. surged nearly 30% in 2020, the tragic result of a deadlier supply and the destabilizing effects of the Covid-19 pandemic, according to preliminary federal data and public health officials...The estimated 93,331 deaths from drug overdoses last year, a record high, represent the sharpest annual increase in at least three decades, and compare with an estimated toll of 72,151 deaths in 2019, according to provisional overdose-drug data released...by the Centers for Disease Control and Prevention...READ MORE
- FDA adds warning about rare heart inflammation to Pfizer, Moderna COVID shots (reuters.com)Pfizer, Moderna COVID-19 vaccines will get label warning over rare heart risk, FDA says (fiercepharma.com)
The U.S. drug regulator...added a warning to the literature that accompanies Pfizer Inc/BioNTech and Moderna COVID vaccine shots to indicate the rare risk of heart inflammation after its use...For each vaccine, the fact sheets for healthcare providers have been revised to include a warning that reports of adverse events suggest increased risks of myocarditis and pericarditis, particularly after the second dose and with onset of symptoms within a few days after vaccination, the FDA said...READ MORE
- Top 10 Errors Related To COVID-19 Vaccination (pharmacypracticenews.com)
Many of the underlying causes of vaccine-related errors are ongoing issues, so health care providers who plan to stock and/or administer COVID-19 vaccines should anticipate the types of errors that can and do happen and take the necessary steps to prepare and mitigate the risk for COVID-19 vaccine–related errors…A recent analysis of more than 160 COVID-19–related event reports submitted to the Institute for Safe Medication Practices National Vaccine Errors Reporting Program from December 14, 2020, through April 17, 2021, underscores that more needs to be done to reduce the risk for vaccination errors because they can lead to inadequate immunity, increased cost, and reduced confidence in the health care delivery system…READ MORE
1. Shoulder injury related to vaccine administration.
2. Not checking/documenting administration in the immunization information system.
3. Wrong diluent.
4. Wrong diluent volume.
5. Errors related to vaccine storage.
7. Administration of air in empty vaccine syringe.
8. Wrong dose.
9. Age-related events.
10. Vaccine competency.
- FDA expected to announce new warning on Johnson & Johnson vaccine related to rare autoimmune disorder (msn.com)
The Food and Drug Administration is preparing to announce a new warning for the Johnson & Johnson coronavirus vaccine saying the shot has been linked to a serious but rare side effect called Guillain-Barré syndrome, in which the immune system attacks the nerves...About 100 preliminary reports of Guillain-Barré have been detected after the administration of 12.8 million doses of Johnson & Johnson vaccine in the United States, the Centers for Disease Control and Prevention said in a statement Monday. The cases have largely been reported about two weeks after vaccination and mostly in men, many aged 50 and older...READ MORE
- Data Supports Use of Anti-Parasitic Drug Ivermectin in COVID-19 Patients, Study Shows (biospace.com)
Use of the anti-parasitic drug ivermectin could reduce COVID-19-related deaths, data from a peer-reviewed study shows...The study, published last week in the American Journal of Therapeutics, analyzed data from multiple clinical studies assessing ivermectin as a potential treatment for COVID-19. Ivermectin, which is approved by the U.S. Food and Drug Administration as a treatment for intestinal strongyloidiasis and onchocerciasis...The latest assessment of those multiple studies seems to confirm the potential of ivermectin against COVID-19. However, the FDA currently maintains a web page warning against the unauthorized use of ivermectin to treat the virus...The FDA notes that clinical studies are underway assessing ivermectin against COVID-19, but until those are reviewed and confirmed, it will warn against taking unauthorized medication...READ MORE
- EU Hits AstraZeneca Vaccine with Another Blood Condition for Side Effect List (biospace.com)
The AstraZeneca COVID-19 vaccine takes another hit to its safety profile as the European Medicines Agency adds a new side effect to the label of its shot…The EMA identified a rare blood condition, capillary leak syndrome, as a potential side effect of AstraZeneca’s Vaxzevria. The condition causes plasma leaks from blood vessels into neighboring body cavities and muscles. Blood pressure experiences a sharp drop as a result, and, left untreated, the disorder can lead to organ failure and death…READ MORE